BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28700662)

  • 1. BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    Kaufmann B; Wang B; Zhong S; Laschinger M; Patil P; Lu M; Assfalg V; Cheng Z; Friess H; Hüser N; von Figura G; Hartmann D
    PLoS One; 2017; 12(7):e0180225. PubMed ID: 28700662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
    Wang P; Song X; Cao D; Cui K; Wang J; Utpatel K; Shang R; Wang H; Che L; Evert M; Zhao K; Calvisi DF; Chen X
    Cell Death Dis; 2020 Feb; 11(2):91. PubMed ID: 32019910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis.
    Liu H; Yue L; Hong W; Zhou J
    Life Sci; 2024 Jun; 347():122605. PubMed ID: 38642845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression.
    Chen Z; Lu X; Jia D; Jing Y; Chen D; Wang Q; Zhao F; Li J; Yao M; Cong W; He X
    Cell Death Dis; 2018 Jan; 9(2):59. PubMed ID: 29352111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.
    Chen L; Li M; Li Q; Wang CJ; Xie SQ
    Mol Cancer; 2013 Dec; 12():157. PubMed ID: 24325363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10.
    Liu Z; Tian Z; Cao K; Zhang B; Wen Q; Zhou X; Yang W; Wang T; Shi H; Wang R
    J Cell Mol Med; 2019 Jan; 23(1):70-82. PubMed ID: 30450735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.
    Watanabe T; Semba S; Yokozaki H
    Br J Cancer; 2011 Jan; 104(1):146-54. PubMed ID: 21102582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
    Chen JS; Su IJ; Leu YW; Young KC; Sun HS
    Int J Cancer; 2012 Mar; 130(6):1302-13. PubMed ID: 21469146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma.
    Li Y; Xu D; Bao C; Zhang Y; Chen D; Zhao F; Ding J; Liang L; Wang Q; Liu L; Li J; Yao M; Huang S; He X
    Oncotarget; 2015 Feb; 6(4):2421-33. PubMed ID: 25537516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide.
    Li L; Liu D; Bu D; Chen S; Wu J; Tang C; Du J; Jin H
    Biochim Biophys Acta; 2013 Jun; 1833(6):1347-55. PubMed ID: 23499876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.
    Saladi SV; Keenen B; Marathe HG; Qi H; Chin KV; de la Serna IL
    Mol Cancer; 2010 Oct; 9():280. PubMed ID: 20969766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.